最新消息

The “Taiwan Biotechnology and Healthcare Forum,” hosted by Business Today, brought together leading experts from academia, clinical medicine, and the biotechnology industry to explore the critical transition toward precision health in Taiwan.

Featured speakers included Dr. Yong Ren Chen, Founder & Managing Director of G CLINIC International Medical System, alongside distinguished leaders from national research institutes, biotechnology companies, and medical centers.

Taiwan is entering a new era of healthcare transformation—one driven by data, technology, and precision medicine.

With a National Health Insurance (NHI) system covering over 99.9% of the population, Taiwan has accumulated one of the most comprehensive healthcare databases in the world. Combined with its globally recognized strength in information and communication technology (ICT), Taiwan is uniquely positioned to lead the development of Bio-ICT—the convergence of biomedical science and digital innovation.

As global supply chains shift toward “non-red” ecosystems, Taiwan is emerging not only as a semiconductor powerhouse, but also as a strategic hub for AI-driven healthcare and precision medicine.

Taiwan’s Transition: From Precision Medicine to Precision Health

Precision medicine represents a paradigm shift in healthcare. Its core principle is:

Delivering the right treatment, at the right dose, to the right patient, at the right time.

 

By integrating genomics, clinical data, and advanced analytics, healthcare is moving beyond generalized treatment toward truly personalized care.

Today, this transformation is expanding further—from precision medicine to precision health—with a stronger emphasis on prevention, early risk detection, and long-term health management.

According to publicly discussed healthcare data in Taiwan, a key challenge lies not only in longevity, but also in the number of years individuals may live in suboptimal health—estimated at approximately 7.5 to 8 years in later life. This highlights the growing importance of shifting healthcare models toward improving healthspan, not just lifespan.

The Power of Data: Taiwan’s Competitive Edge

At the core of this transformation lies data.

Taiwan’s NHI system, combined with decades of accumulated clinical records, provides a unique foundation for large-scale medical analysis. This data ecosystem enables:

• Early disease risk prediction
• Personalized treatment strategies
• Improved drug efficacy and reduced side effects
• AI-driven clinical decision support

In parallel, under Taiwan’s evolving regulatory framework, more than 300 medical institutions have participated in cell therapy-related practice, with over 450 clinical cases conducted and more than 2,000 patients having received such treatments. These developments reflect the growing momentum of regenerative medicine in Taiwan, while also underscoring the importance of structured clinical frameworks, long-term follow-up, and integrated care systems.

As global healthcare systems increasingly rely on data integration, Taiwan has the potential to become a global data hub for precision healthcare.

G CLINIC’s Approach: Integrating Medicine, Technology, and Preventive Care

Dr. Yong Ren Chen discussed Taiwan’s healthcare challenges and the growing role of precision and regenerative medicine, emphasizing the need for long-term, integrated care.

Within this evolving landscape, Dr. Yong Ren Chen, Founder & Managing Director of G CLINIC International Medical System, is advancing a new model of healthcare delivery.

G CLINIC focuses on integrating:

• Preventive medicine
• Smart healthcare technologies
• Clinical diagnosis and treatment

into a unified, patient-centered system.

Rather than treating disease in isolation, this approach emphasizes early intervention, systemic health management, and personalized care pathways—aligning closely with the global transition toward precision health.

This approach reflects G CLINIC’s commitment to extending not only lifespan, but more importantly, healthspan—enhancing quality of life through structured, continuous, and personalized care.

Through international collaborations, including projects in Macau, G CLINIC is also exploring innovative service models that combine healthcare, wellness, and lifestyle integration—bringing Taiwan’s advanced medical capabilities to the global stage.

Start Your Precision Health Journey

For individuals seeking a more personalized and proactive approach to health, G CLINIC provides structured consultation services designed to evaluate individual health conditions, risk factors, and long-term wellness goals.

Through a comprehensive assessment process, our team works with each individual to explore suitable care strategies based on medical data, lifestyle factors, and clinical insights.

If you would like to learn more about our approach to precision health, we welcome you to connect with our team for further information.

Contact us to explore your personalized health strategy.

A Global Vision for the Next Healthcare Era

Taiwan’s success in semiconductors has demonstrated its ability to lead in complex, high-tech industries.

Today, by leveraging its strengths in data, AI, and Bio-ICT, Taiwan is building a second growth engine—one centered on healthcare innovation.

For G CLINIC, this represents more than an industry trend.
It is a long-term commitment to redefining healthcare:

• From reactive treatment to proactive prevention
• From standardized care to personalized medicine
• From local services to globally connected healthcare ecosystems

The forum highlighted that advancing new medical approaches requires not only technological innovation, but also integration across clinical systems, multidisciplinary collaboration, and long-term healthcare management.

As discussions concluded, experts emphasized that the future of precision health will depend on the effective integration of big data, bridging research, clinical application, and preventive care—starting from community-level healthcare and extending to a broader, system-wide transformation.

As healthcare continues to evolve, the integration of data, technology, and medicine will define the next generation of medical systems.

Leveraging Taiwan’s world-leading healthcare data infrastructure and Bio-ICT capabilities, G CLINIC International Medical System is committed to advancing precision health—transforming clinical medicine into a predictive, personalized, and globally connected model of care.